Quantinno Capital Management LP Medpace Holdings, Inc. Transaction History

Quantinno Capital Management LP

$15 Billion
Q1 2025

A detailed history of Quantinno Capital Management LP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 2,631 shares of MEDP stock, worth $791,878. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,631

Previous 1,148 129.18%

Holding current value

$791,878

Previous $381,000 110.24%

% of portfolio

0.01%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$304.69 - $360.97 $451,855 - $535,318	1,483 Added 129.18%	2,631 $801,000
Q4 2024 Feb 14, 2025	BUY	$308.93 - $363.58 $106,580 - $125,435	345 Added 42.96%	1,148 $381,000
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $7,693 - $10,974	24 Added 3.08%	803 $267,000
Q2 2024 Aug 14, 2024	BUY	$372.0 - $424.34 $54,312 - $61,953	146 Added 23.06%	779 $320,000
Q1 2024 May 14, 2024	BUY	$284.87 - $413.31 $180,322 - $261,625	633 New	633 $255,000
Q2 2020 Aug 14, 2020	SELL	$68.08 - $95.68 $591,751 - $831,650	-8,692 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$61.71 - $101.95 $536,383 - $886,149	8,692 New	8,692 $638,000
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $190,547 - $230,136	-2,719 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $36,118 - $49,730	-579 Reduced 17.56%	2,719 $229,000
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $26,712 - $32,579	-498 Reduced 13.12%	3,298 $216,000
Q1 2019 May 14, 2019	BUY	$49.38 - $70.58 $187,446 - $267,921	3,796 New	3,796 $224,000

Others Institutions Holding MEDP

# of Institutions

626

Shares Held

26M

Call Options Held

46.4K

Put Options Held

80.8K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.36B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.

Account

Quantinno Capital Management LP Medpace Holdings, Inc. Transaction History